Dr. Stanley Crooke is the founder, chairman and chief executive officer of Ionis Pharmaceuticals. Under his leadership, Ionis pioneered development of the revolutionary antisense technology platform and created one of the largest, most advanced pipelines in the biotechnology industry. Today, Ionis has more than 40 medicines in development.
Prior to founding Ionis, Dr. Crooke was head of R&D at SmithKline. Earlier at Bristol-Myers, he established the first broad anticancer program, bringing nine drugs to the market in five years.